Literature DB >> 24682556

[Not Available].

G Wiesner1, J Grimm, E Bittner.   

Abstract

Based on the Federal Health Survey from 1998, the Augsburg heart attack registry, and the ninth coordinated population prediction, we have estimated the occurrence of heart attacks in Germany up to the year 2050. From the mere demographic perspective - regardless of medical and social influences - we can expect that the need for cardiac care will increase considerably. If we assume that the risk or the frequency of having a heart attack will remain the same, then the number of heart attacks in people aged 25 to over 90 and 35 to under 90 will increase, although the population size of these age groups will decline. The population over 75 years of age will with certainty determine the course of the incidence and prevalence of heart attacks. In addition to standardised incidence and/or prevalence rates, estimations of the absolute number of incidents and/or prevalent cases of the respective target illness have to be included in morbidity predictions in order to avoid misinterpretations.

Entities:  

Year:  2002        PMID: 24682556     DOI: 10.1007/s00103-002-0405-4

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  5 in total

Review 1.  ["Anti-aging" from a cardiologist's view].

Authors:  U Laufs; M Böhm
Journal:  Urologe A       Date:  2004-05       Impact factor: 0.639

2.  [Influence of the demographic change on hospital admissions and costs in Germany].

Authors:  Janine Biermann; Anja Neumann; Alexander Hewer; Jürgen Wasem; Raimund Erbel; Till Neumann
Journal:  Med Klin (Munich)       Date:  2011-01-16

3.  Cost-effectiveness of adjunctive eptifibatide in patients undergoing coronary stenting in Germany.

Authors:  Sarah Dewilde; Bernd Brüggenjürgen; Christoph Nienaber; Jochen Senges; Robert Welte; Stefan N Willich
Journal:  Eur J Health Econ       Date:  2011-04-12

4.  Effect of patient's age on the profitability of inpatient cardiac catheterization: a contribution margin analysis of frequently performed procedures over a 5-year period.

Authors:  Gunnar Plehn; Thomas Butz; Petra Maagh; Axel Meissner
Journal:  BMC Health Serv Res       Date:  2017-01-18       Impact factor: 2.655

5.  Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany.

Authors:  Ulrike Theidel; Christian Asseburg; Evangelos Giannitsis; Hugo Katus
Journal:  Clin Res Cardiol       Date:  2013-03-09       Impact factor: 5.460

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.